Author

Quentin Duchemin

ETH ZurichORCID 0000-0003-3636-3770Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:multiome· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Anne BertoliniiD· 1 shared Berend SnijderiD· 1 shared Daniel Johannes StekhoveniD· 1 shared Daniel Trejo BanosiD· 1 shared Franziska SingeriD· 1 shared Guillaume ObozinskiiD· 1 shared Jack KuipersiD· 1 shared Matthias LienhardiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anne BertoliniORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintMay 11, 2026

Clone-level multi-modal prediction of tumour drug response

Quentin Duchemin, Daniel Trejo Banos, Anne Bertolini…·Jack Kuipers

This paper introduces scClone2DR, a framework predicting tumour drug response at the clone level using single-cell DNA/RNA sequencing and drug-screening data, showing improved accuracy in identifying clonal sensitivities and resistance.

DOI 10.64898/2026.05.06.723206

humanscRNA-seq

𝕏 PostBluesky